• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Thor Medical

Less than 1K followers

TRMED

Oslo Børs

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus

Thor Medical is a manufacturer and supplier of alpha particle emitters for cancer treatment. Radionuclide therapy (RNT) or radioligand therapy (RLT) using alpha particle emitters is a promising technology for cancer treatment. The main focus of the company is to refine the production technology, secure the customer base and necessary regulatory approvals for industrialization. Thor Medical is headquartered in Oslo.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
28.8.
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Regulatory press release5/29/2026, 5:00 AM

TRMED: Thor Medical Enters Partnership Agreement with Minerva Imaging to Support Availability of Lead-212 in Europe

Thor Medical
Regulatory press release5/28/2026, 5:00 AM

TRMED: Thor Medical Enters Partnership with Eckert & Ziegler to Enable Access of Lead-212 for the Pharmaceutical Industry

Thor Medical
Regulatory press release5/8/2026, 1:51 PM

Thor Medical ASA: New share capital registered

Thor Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release5/5/2026, 12:29 PM

Thor Medical - Issuance of RSU shares and grant of RSUs to members of the board

Thor Medical
Regulatory press release4/23/2026, 1:44 PM

Thor Medical ASA: Completion of the Annual General Meeting

Thor Medical
Regulatory press release4/17/2026, 5:00 AM

Thor Medical ASA: Mechanical Completion Achieved at Herøya Facility, AlphaOne

Thor Medical
Regulatory press release4/10/2026, 7:51 AM

Thor Medical ASA - Nomination committee recommendation to the Annual General Meeting

Thor Medical
Regulatory press release4/1/2026, 6:00 AM

Thor Medical ASA - Notice of Annual General Meeting on 23 April 2026

Thor Medical
Regulatory press release3/27/2026, 7:00 AM

Thor Medical ASA: Annual Report 2025

Thor Medical
Regulatory press release3/26/2026, 6:00 AM

TRMED: Thor Medical Enters into an Agreement with Node Pharma for Supply of Radium-224 and Lead-212

Thor Medical
Regulatory press release3/18/2026, 7:54 PM

TRMED: Financial calendar

Thor Medical
Regulatory press release3/18/2026, 7:31 PM

TRMED: Financial calendar

Thor Medical
Regulatory press release3/13/2026, 9:19 AM

Thor Medical ASA - New share capital registered

Thor Medical
Regulatory press release3/2/2026, 6:41 PM

Thor Medical ASA - Completed primary insider purchases after option exercise

Thor Medical
Regulatory press release2/27/2026, 9:39 AM

Thor Medical ASA - Exercise of share options and resolution to increase share capital

Thor Medical
Regulatory press release2/26/2026, 6:00 AM

Thor Medical ASA: Second-Half and Full-Year 2025 Results - AlphaOne on Track, Backed by Strong Commercial Momentum

Thor Medical
Regulatory press release2/18/2026, 6:00 AM

Thor Medical ASA: Invitation to Presentation of Second-Half and Full-Year 2025 Results

Thor Medical
Regulatory press release1/6/2026, 7:52 AM

Thor Medical - Issuance of shares to executive member under incentive program

Thor Medical
Regulatory press release12/23/2025, 7:00 AM

TRMED: Thor Medical reaches key construction milestones at AlphaOne plant

Thor Medical
Regulatory press release12/4/2025, 7:00 AM

TRMED: RadioMedix and Thor Medical enter supply agreement for thorium-228

Thor Medical